Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for IDEAYA Biosciences (IDYA) over the last 5 years, with Q2 2025 value amounting to $88.5 million.

  • IDEAYA Biosciences' Shares Outstanding (Diluted Average) rose 1348.01% to $88.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $88.5 million, marking a year-over-year increase of 1348.01%. This contributed to the annual value of $81.7 million for FY2024, which is 4199.96% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Shares Outstanding (Diluted Average) stood at $88.5 million for Q2 2025, which was up 1348.01% from $88.4 million recorded in Q1 2025.
  • In the past 5 years, IDEAYA Biosciences' Shares Outstanding (Diluted Average) ranged from a high of $88.5 million in Q2 2025 and a low of $35.3 million during Q4 2021
  • Over the past 5 years, IDEAYA Biosciences' median Shares Outstanding (Diluted Average) value was $60.0 million (recorded in 2023), while the average stood at $64.4 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Shares Outstanding (Diluted Average) soared by 5527.88% in 2024 and then surged by 1348.01% in 2025.
  • IDEAYA Biosciences' Shares Outstanding (Diluted Average) (Quarter) stood at $35.3 million in 2021, then rose by 17.57% to $41.4 million in 2022, then skyrocketed by 38.79% to $57.5 million in 2023, then surged by 42.0% to $81.7 million in 2024, then grew by 8.32% to $88.5 million in 2025.
  • Its last three reported values are $88.5 million in Q2 2025, $88.4 million for Q1 2025, and $81.7 million during Q4 2024.